Zobrazeno 1 - 10 of 1 201 pro vyhledávání: '"J S, Andersen"'
1
AB1254 PHENOTYPING OF MULTIPLE BIOFLUIDS FOR LIQUID BIOMARKERS FOR DIAGNOSTICS AND PERSONALIZED MEDICINE OF RHEUMATOID ARTHRITIS, SPONDYLOARTHRITIS AND OSTEOARTHRITIS
Autor: L. Arent-Nielsen, Allan Stensballe, M. K. Kristiansen, S. Rasmusen, J. S. Andersen, Claus Henrik Nielsen, Thomas Poulsen
Publikováno v: Annals of the Rheumatic Diseases. 79:1918.1-1919
Background:Inflammatory and autoimmune diseases include multifactual pathomechanisms and systemic responses. The etiology of the joint diseases rheumatoid arthritis (RA), spondyloarthritis (SpA) in relation to osteoarthritis (OA) remain incomplete an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c7c9758b45904d44751df34c25d1b406
https://doi.org/10.1136/annrheumdis-2020-eular.5949
Zobrazit plný text záznamu
3
Akademický článek
A Damaging COL6A3 Variant Alters the MIR31HG‐Regulated Response of Chondrocytes in Neocartilage Organoids to Hyperphysiologic Mechanical Loading.
Autor: Bloks, Niek GC1 (AUTHOR), Harissa, Zainab2,3 (AUTHOR), Mazzini, Giorgia1 (AUTHOR), Adkar, Shaunak S2,3 (AUTHOR), Dicks, Amanda R2,3 (AUTHOR), Hajmousa, Ghazaleh1 (AUTHOR), Steward, Nancy2,3 (AUTHOR), Koning, Roman I.1 (AUTHOR), Mulder, Aat1 (AUTHOR), de Koning, Berend B.R.1 (AUTHOR), Kloppenburg, Margreet1 (AUTHOR), de Almeida, Rodrigo Coutinho1 (AUTHOR), Ramos, Yolande FM1 (AUTHOR), Guilak, Farshid2,3 (AUTHOR), Meulenbelt, Ingrid1 (AUTHOR) i.meulenbelt@lumc.nl
Publikováno v: Advanced Science. 9/25/2024, Vol. 11 Issue 36, p1-15. 15p.
Zobrazit plný text záznamu
4
Akademický článek
Group Response-Adaptive Randomization With Delayed and Missing Responses.
Autor: Zhai G; Department of Statistics, George Washington University, Washington, DC., Li Y; Center for Applied Statistics, School of Statistics, Renmin University of China, Beijing, People's Republic of China., Zhang L; School of Statistics and Mathematics, Zhejiang Gongshang University, Zhejiang, People's Republic of China.; School of Mathematical Sciences, Zhejiang University, Zhejiang, People's Republic of China., Hu F; Department of Statistics, George Washington University, Washington, DC.
Publikováno v: Statistics in medicine [Stat Med] 2024 Sep 16. Date of Electronic Publication: 2024 Sep 16.
Zobrazit plný text záznamu
5
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial
Autor: M. C. Cripps, A M Storniolo, M R Green, P Tarassoff, R Nelson, Mace L. Rothenberg, M R Modiano, F A Dorr, J. S. Andersen, D. D. Von Hoff, C. D. Stephens, H. A. Burris, Malcolm J. Moore, Russell K. Portenoy
Publikováno v: Journal of Clinical Oncology. 15:2403-2413
PURPOSE Most patients with advanced pancreas cancer experience pain and must limit their daily activities because of tumor-related symptoms. To date, no treatment has had a significant impact on the disease. In early studies with gemcitabine, patient
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08fc9a953e2fb7fceb4ac7f8c849fc8f
https://doi.org/10.1200/jco.1997.15.6.2403
Zobrazit plný text záznamu
6
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
Autor: T. D. Brown, M. L. Rothenberg, Mark R. Green, J. S. Andersen, Ephraim S. Casper, Russell K. Portenoy, Anna Maria Storniolo, Peter Tarassoff, M. C. Cripps, H. A. Burriss, D. D. Von Hoff, Malcolm J. Moore
Publikováno v: Annals of Oncology. 7:347-353
PURPOSE To assess the effect of gemcitabine in patients with metastatic pancreas cancer that had progressed despite prior treatment with 5-FU. PATIENTS AND METHODS Seventy-four patients were enrolled in this multicenter trial. Alleviation of cancer-r
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5537c6b5f563ca0821ffd0ca4aa6c396
https://doi.org/10.1093/oxfordjournals.annonc.a010600
Zobrazit plný text záznamu
7
Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials
Autor: S R, Durham, A O, Birk, J S, Andersen
Publikováno v: Allergy. 66(1)
In immunotherapy trials, primary and secondary endpoints often focus on average symptom and medication scores during the pollen season or on days with low symptoms and low medication use. Thus, there is a need for endpoints describing the treatment e
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::39cb1016aab8b198a2c1a3d9996c8771
https://pubmed.ncbi.nlm.nih.gov/20608918
Zobrazit plný text záznamu
9
Sustained effect of SQ-standardized grass allergy immunotherapy tablet on rhinoconjunctivitis quality of life
Autor: L, Frølund, S R, Durham, M, Calderon, W, Emminger, J S, Andersen, P, Rask, R, Dahl
Publikováno v: Allergy. 65(6)
The prevalence of allergic rhinoconjunctivitis has increased significantly over the past decades with grass pollen being a common trigger. The impact of allergy on patient's quality of life is substantial.To investigate the sustained effect on qualit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::396e00f008dba9baa87475ed184361a4
https://pubmed.ncbi.nlm.nih.gov/19886920
Zobrazit plný text záznamu
10
Atrial fibrillation and left atrial enlargement: cause or effect?
Autor: J. S. Andersen, J. Godtfredsen, H. Egeblad, Ulrik Abildgaard, J. Aldershvile
Publikováno v: Journal of Internal Medicine. 229:253-256
In a blinded controlled study, 58 consecutive patients with definite left atrial enlargement (M-mode dimension of at least 45 mm) were followed up after 1-2 years. The aim of the study was to examine the following: (a) the prospective risk of develop
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a855de0a63b7a42ff875535c5bc77a94
https://doi.org/10.1111/j.1365-2796.1991.tb00340.x
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje